XMIL
AIW
Market cap145mUSD
Nov 12, Last price
4.24EUR
Name
Almawave SpA
Chart & Performance
P/E
14.79
P/S
2.59
EPS
0.29
Div Yield, %
—
Shrs. gr., 5y
2.32%
Rev. gr., 5y
18.14%
Revenues
49m
-14.69%
Net income
9m
-7.50%
CFO
10m
-11.03%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Almawave S.p.A., an Italian company, delivers specialized services in artificial intelligence (AI), natural language processing (NLP), and big data. Its product portfolio includes Iride, a flexible AI suite that integrates text, voice, and advanced algorithms to significantly improve customer experience, optimize operational workflows, enable sophisticated data analysis, and ensure robust data governance. The company also provides Audioma, a comprehensive speech recognition platform fluent in approximately 30 languages, offering services such as transcription, subtitling, automated translation, and command-and-control capabilities. For audio and video media, Verbamatic offers an automatic indexing solution, complete with speech-to-text transcription and content search functionalities. Furthermore, FlyScribe is a versatile multi-language platform designed for automatic and on-demand transcription of diverse materials like board meetings, event subtitling for accessibility, and the creation of audio guides. Alongside these solutions, Almawave extends its expertise through consulting services. The company caters to a broad spectrum of industries, including government, transportation, telecommunications, media, utilities, healthcare, and financial services. Founded in 2008 and based in Rome, Italy, Almawave S.p.A. operates as a subsidiary of Almaviva - The Italian Innovation Company S.p.A.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||